Company: JUNS
Filing Date: 2025-11-26
Form Type: S-1
Source: 0001493152-25-025204
Chunk: 180

Company: JUPITER NEUROSCIENCES, INC.
Filing Date: 2025-11-26
Form: S-1
Chunk 180
---
 Committee”), which consists of three independent directors: Holger Weis, Allison W. Brady and Nicholas Hemmerly.
Mr. Weis is the chair of the Audit Committee. Mr. Weis qualifies as an audit committee financial expert under SEC rules and as a financially
sophisticated audit committee member under the Nasdaq rules. Our Audit Committee operates under a written charter that is reviewed annually.
A copy of the charter is posted on the Corporate Governance section of our website, at www.jupiterneurosciences.com.

Our Audit Committee is authorized
to:

| ● | approve and retain the independent auditors to conduct the annual 
 audit of our financial statements;                                |

| ● | review the proposed scope and results of the audit; |

| ● | review and pre-approve audit and non-audit fees and services; |

| ● | review accounting and financial controls with the independent 
 auditors and our financial and accounting staff;              |

| ● | review and approve transactions between us and our directors, 
 officers and affiliates;                                      |

| ● | recognize and prevent prohibited non-audit services; |

| ● | establish procedures for complaints received by us regarding 
 accounting matters; and                                      |

| ● | oversee internal audit functions, if any. |

Compensation Committee

We have established a compensation
committee (“Compensation Committee”), which consists of three independent directors: Nicholas H. Hemmerly, Julie Kampf and
Allison Brady. Mr. Hemmerly is the chair of the Compensation Committee. Our Compensation Committee operates under a written charter that
is reviewed annually. A copy of the charter is posted on the Corporate Governance section of our website, at www.jupiterneurosciences.com.

| 102 |

The Compensation Committee
is authorized to:

| ● | review and determine the compensation arrangements for management; |

| ● | establish and review general compensation policies with the objective to attract and retain superior talent, 
 to reward individual performance and to achieve our financial goals;                                         |

| ● | administer our incentive compensation and benefit plans and purchase plans; |

| ● | oversee the evaluation of the Board of Directors and management; and |

| ● | review the independence of any compensation advisers. |

Nominating and Corporate Governance Committee

We have established a nominating
and corporate governance committee (“Nominating and Corporate Governance Committee”), which consists of three independent
directors: Julie Kampf, Holger Weis and Nicholas H. Hemmerly. Ms. Kampf is the chair of the Nominating